MENZIES SCHOOL OF HEALTH RESEARCH

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1985-01-01

Employees: 251

Market Cap: -

Website: https://www.menzies.edu.au

Clinical Trials

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Phase 3

Recruiting

Conditions: Vivax Malaria

Interventions: Drug: Tafenoquine
Drug: Primaquine

First Posted Date: 2023-11-28

Last Posted Date: 2024-08-29

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 1090

Registration Number: NCT06148792

Locations: 🇪🇹
Arba Minch General Hospital, Arba Minch, Ethiopia
🇵🇬
Dr Moses Laman and Dr Brioni Moore, Alexishafen, Papua New Guinea
🇮🇩
Dr Rini Poespoprodjo, Timika, Indonesia

and more 1 locations

Non-Expert Acquisition & Remote Expert Review of Screening Echocardiography Images From Child Health & AnteNatal Clinics

Not Applicable

Not yet recruiting

Conditions: Rheumatic Heart Disease

Interventions: Diagnostic Test: SPLASH echocardiography screening

First Posted Date: 2023-08-21

Last Posted Date: 2024-03-18

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 1500

Registration Number: NCT06002243

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

Not Applicable

Recruiting

Conditions: Vivax Malaria
G6PD Deficiency

Interventions: Combination Product: Revised case management package

First Posted Date: 2023-05-30

Last Posted Date: 2024-02-05

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 11250

Registration Number: NCT05879224

Locations: 🇮🇩
Puskesmas Tanjung Leidong, Labuhanbatu, North Sumatra, Indonesia
🇮🇩
Puskesmas Hanura, Hanura, Lampung, Indonesia
🇮🇩
Puskesmas Pasar Sentral, Mimika, Papua, Indonesia

and more 3 locations

The Communicate Study Partnership

Phase 2

Recruiting

Conditions: Healthcare Provider Training
Aboriginal Health
Cultural Safety
Access to Interpreters

Interventions: Behavioral: Interventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples

First Posted Date: 2022-11-29

Last Posted Date: 2023-02-16

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 340

Registration Number: NCT05629416

Locations: 🇦🇺
Royal Darwin Hospital, Darwin, Northern Territory, Australia
🇦🇺
Palmerston Hospital, Darwin, Northern Territory, Australia
🇦🇺
Katherine Hospital, Katherine, Northern Territory, Australia

and more 1 locations

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Phase 3

Active, not recruiting

Conditions: Malaria
Malaria in Pregnancy
Pregnancy Related

Interventions: Drug: Dihydroartemisinin-Piperaquine (DP)
Drug: Sulfadoxine pyrimethamine (SP)

First Posted Date: 2022-06-22

Last Posted Date: 2024-08-29

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 1172

Registration Number: NCT05426434

Locations: 🇵🇬
Papua New Guinea Institute of Medical Research, Madang, Madang Province, Papua New Guinea

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Phase 3

Completed

Conditions: Vivax Malaria
Plasmodium Vivax
Malaria, Vivax
Malaria Relapse

Interventions: Drug: Primaquine
Drug: Tafenoquine

First Posted Date: 2020-06-02

Last Posted Date: 2024-10-07

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 960

Registration Number: NCT04411836

Locations: 🇵🇰
Aga Khan Hospital Karachi, Karachi, Pakistan
🇰🇭
Kravanh District Hospital, Pursat, Pursat Province, Cambodia
🇰🇭
Siem Pang Health Centre, Stung Treng, Cambodia

and more 3 locations

Short Course Radical Cure of P. Vivax Malaria in Nepal

Phase 4

Completed

Conditions: Malaria
Malaria, Vivax
Malaria,Falciparum

Interventions: Drug: primaquine

First Posted Date: 2019-09-06

Last Posted Date: 2024-08-29

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 27

Registration Number: NCT04079621

Locations: 🇳🇵
Tikapur Hospital, Tikapur, Nepal
🇳🇵
Malakheti Hospital, Malakheti, Nepal

Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas

Phase 4

Completed

Conditions: Falciparum Malaria
Malaria
Vivax Malaria

Interventions: Drug: primaquine

First Posted Date: 2019-04-16

Last Posted Date: 2023-11-21

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 500

Registration Number: NCT03916003

Locations: 🇪🇹
Arba Minch University, Arba Minch, Ethiopia
🇧🇩
Icddrb, Upazila, Bangladesh
🇮🇩
Puskesmas Mangili, Dusun Tenggara, Indonesia

Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

Not Applicable

Active, not recruiting

Conditions: Otitis Media
Conductive Hearing Loss

Interventions: Behavioral: facilitator

First Posted Date: 2019-04-16

Last Posted Date: 2024-03-15

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 18

Registration Number: NCT03916029

Locations: 🇦🇺
Ampilatwatja, Ampilatwatja, Northern Territory, Australia
🇦🇺
Palumpa Community Health Centre, Palumpa, Northern Territory, Australia
🇦🇺
Darwin, Darwin, Northern Territory, Australia

and more 17 locations

Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria

Completed

Conditions: Sepsis
Bacteremia
Malaria

First Posted Date: 2017-07-21

Last Posted Date: 2024-03-15

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 20

Registration Number: NCT03224052

Locations: 🇲🇲
Insein General Hospital, Yangon, Myanmar

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy